Schaeffer's Options Center
Sponsored by:
Schaeffer's Daily Option Blog

Bulls Bet on MannKind to Break Through Resistance

Biotech stock MNKD drew a heavy dose of call volume on Tuesday

by 8/29/2012 9:56 AM
Stocks quoted in this article:

Options players set their sights on MannKind Corporation (NASDAQ:MNKD - 2.90) on Tuesday, with overall volume rising to triple the usual level. All told, 7,454 calls and 1,487 puts changed hands on the biotech stock during the course of the session, with traders focusing their energy on a pair of January-dated strikes.

Most active was the January 2013 3-strike call, where 2,207 contracts were exchanged. Quite a few of these options were bought to open, although a handful of liquidations resulted in a relatively modest overnight open interest gain of 322 contracts.

Meanwhile, 1,150 contracts crossed the tape on MNKD's January 2014 3-strike call, where open interest climbed by 827 contracts overnight. Similar to their January 2013-dated counterparts, the bulk of these calls traded near the ask price -- pointing to buyer-driven volume.

With MNKD hovering around $2.90, these 3-strike calls are out of the money by a slim margin. The stock has gained a respectable 11.2% year-to-date, and MNKD is currently on track for a rare weekly close above its 50-week moving average. However, the shares are now facing off with their 80-week trendline, located at $2.94. This moving average hasn't been surmounted on a weekly closing basis since mid-January 2011.

Weekly Chart of MNKD since December 2010 With 50-Week and 80-Week Moving Averages


Featured Brokers
Unusual Option Volume
Option Flow
Most Active Stocks
Most Active Option Strikes
Largest Open Interest

Partner Center

© 2015 Schaeffer's Investment Research, Inc. 5151 Pfeiffer Road, Suite 250, Cincinnati, Ohio 45242 Phone: (800) 448-2080 FAX: (513) 589-3810 Int'l Callers: (513) 589-3800 Email:

All Rights Reserved. Unauthorized reproduction of any SIR publication is strictly prohibited.

Market Data provided by | Data delayed 15-20 minutes unless otherwise indicated.